cTnI, CK-MB and Myoglobin (troponin, Creatine kinase-MB, Myglobin)
Rapid CDIATM cTnI, CK-MB and Myoglobin kits are intended for the rapid diagnosis of heart attack and risk stratification of acute coronary syndrome.
Troponin is more specific for heart injury and remains elevated for a longer period of time. However, the prolonged release pattern of both CK-MB mass and cardiac troponins makes it difficult to identify the origin of recent chest pain. Myoglobin is among the earliest markers after the onset of ACS symptoms. However, its clinical value is considerably limited by low specificity for cardiac muscle. Thus a combination of early and later biomarkers can facilitate the diagnosis. Multi-marker approach is recommended for rapid diagnostics and risk stratification of acute coronary syndrome.